Skip to main content

Dianthus Therapeutics, Inc.

DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001690585

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Dianthus Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of DNTH: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders9196+5
Shares31.4M35.1M+3.76M (+12.0%)
Value$858.7M$765.7M−$93.0M (−10.8%)

New holders (17)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to DNTH in Q4 2024
InstitutionSharesValue% of portfolio
TCG Crossover Management, LLC1,501,624$32.7M3.20%
Catalio Capital Management, LP763,471$16.6M3.64%
Adage Capital Partners GP, L.L.C.180,000$3.92M0.01%
Ally Bridge Group (NY) LLC106,434$2.32M1.99%
Allostery Investments LP25,000$545.0K1.07%
Susquehanna International Group, LLP16,522$360.2K0.00%
Intech Investment Management LLC9,243$201.5K0.00%
Police & Firemen's Retirement System of New Jersey5,765$125.7K0.00%
BNP Paribas Arbitrage, SA2,695$58.8K0.00%
KBC Group NV1,593$35.0K0.00%
KLP Kapitalforvaltning AS1,500$32.7K0.00%
R Squared Ltd1,200$26.2K0.03%
Crowley Wealth Management, Inc.221$4.82K0.00%
SRS Capital Advisors, Inc.32$6980.00%
Caitong International Asset Management Co., Ltd13$2830.00%
IFP Advisors, Inc0$2620.00%
SBI Securities Co., Ltd.7$1530.00%

Sold out (12)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.